Billionaire Johann Rupert’s South African investment vehicle, Remgro, has officially taken full control of Mediclinic Holdings’ Southern Africa business unit, signalling the end of a complex deal with Luxembourg-based Investment Holding Limited (IHL) to divide their shared stakes in the business, reports Daily Investor.
First announced in December 2025, the transaction has complied with multiple regulatory hoops in South Africa and Europe to reach completion.
Previously, Remgro and IHL were co-shareholders in Mediclinic Holdings, each holding 50% of the healthcare giant, but announced in December that they had reached an agreement to split their stakes.
This transaction sees Remgro owning 100% of the group’s Southern Africa operations, held in Mediclinic International, and IHL owning 100% of the Swiss-based operations, housed in the Hirslanden Group.
The Competition Tribunal gave Remgro the green light in mid-June 2026, and yesterday (Wednesday), the company announced that all other conditions had been fulfilled.
Remgro, which ended up paying $947m, while IHL paid $1.08bn, has said the deal will allow each company to tailor their strategies to better align with regional market dynamics, positioning them for greater value, stronger local partnerships, and greater brand presence.
See more from MedicalBrief archives:
R16bn deal clinches Remgro’s full control of Mediclinic
Mediclinic and Remgro reach agreement on buyout offer